1. ScholarBank@NUS

Eng King Tan

rp09622

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Eng King Tan
Variants
Tan, E.-K.
Tan, E.K.
 
Main Affiliation
 
Faculty
 
Email
gmstek@nus.edu.sg
 

Publications

Results 101-120 of 125 (Search time: 0.007 seconds).

Issue DateTitleAuthor(s)
1012014Digit span: A comparison of Chinese versus alphabetic language speakers in dysexecutive dementia patientsTing S.K.S. ; Hameed S. ; Tan E.-K. ; Gabriel C.; Doshi K.
102Dec-2010Development of Parkinson's disease biomarkersPrakash, K.M.; Tan, E.-K. 
1032016Depression, anxiety, and apathy in Parkinson's disease: Insights from neuroimaging studiesWen M.-C. ; Chan L.L. ; Tan L.C.S. ; Tan E.K. 
42014Deciphering the function and regulation of microRNAs in Alzheimer's disease and Parkinson's diseaseQiu L.; Zhang W.; Tan E.K. ; Zeng L. 
52020Current Status of Stem Cell-Derived Therapies for Parkinson’s Disease: From Cell Assessment and Imaging Modalities to Clinical TrialsJang, S.E.; Qiu, L.; Chan, L.L. ; Tan, E.-K. ; Zeng, L. 
62020Corrigendum: Gut–Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease (Front. Neurol., (2020), 11, (849), 10.3389/fneur.2020.00849)Chao, Y.-X.; Gulam, M.Y.; Chia, N.S.J.; Feng, L. ; Rotzschke, O.; Tan, E.-K. 
72015COQ2 gene variants associate with cerebellar subtype of multiple system atrophy in ChineseLin C.-H.; Tan E.-K. ; Yang C.-C.; Yi Z.; Wu R.-M.
82015Considerations of long-term pain evaluation post-deep brain stimulation surgeryDeng X.; Thomas J.; Tan E.-K. 
92014Consensus-based clinical practice recommendations for the examination and management of falls in patients with Parkinson's diseasevan der Marck M.A.; Klok M.P.; Okun M.S.; Giladi N.; Munneke M.; Bloem B.R.; Arney K.; Browner N.M.; Caunter M.; Cianci H.J.; Dunlop B.; Eggert K.; Fisher B.; Hass C.J.; Hunter C.; Jabre M.; Kraakevik J.; Lyons K.E.; Phibbs F.; Scott B.L.; Shih L.; Tan E.-K. ; Tan L.; Varanese S.; Voss T.; Ashburn A.; Ballinger C.; Bhatti M.T.; Hausdorff J.; Lindvall S.; Morris M.E.; Nieuwboer A.; Schwalb J.M.; Studenski S.; Wood B.H.
102007Comparing LRRK2 Gly2385Arg Carriers with noncarriers [4]Tan E.-K. ; Fook-Chong S. ; Yi Z.
11Sep-2011Clinical evidence linking coffee and tea intake with Parkinson's diseasePrakash, K.M.; Tan, E.-K. 
122016Chromosomal deletion at 22q11.2 and Parkinson's diseaseTan E.-K. 
132001Choosing dopamine agonists in Parkinson's diseaseTan E.-K. ; Jankovic J.
142015CHCHD2 and Parkinson's diseaseFoo J.N.; Liu J.; Tan E.-K. 
152010Changing of the GuardTan E.-K. 
16Mar-2012Camptocormia in Parkinson's disease: Dystonia or myopathy?Peeraully, T.; Tan, E.-K. 
172001Bruxism in Huntington's disease (multiple letters) [2]Louis E.D.; Tampone E.; Jankovic J.; Tan E.K. ; Ondo W.
182017B vitamins and cognition in subjects with small vessel disease: A Substudy of VITATOPS, a randomized, placebo-controlled trialTing S.K.S. ; Earnest A. ; Li H. ; Hameed S. ; Chang H.M. ; Chen C.L.H. ; Tan E.-K. 
192003Autosomal Dominant Spinocerebellar Ataxias: An Asian PerspectiveTan E.K. 
202018Association of LRRK2 haplotype with age at onset in Parkinson diseaseXiao B.; Deng X.; Ng E.Y.-L.; Allen J.C. ; Jr.; Lim S.-Y.; Ahmad-Annuar A.; Tan E.-K.